William Gerber, a non-independent member of the Nanogen's board of directors, resigned from the board effective May 1, the company said this week.
Nanogen said Gerber’s resignation restores compliance with Nasdaq Marketplace Rule 4350(c)(1), which requires a majority of members of the board of directors to be comprised of independent directors.
The non-compliance resulted from the appointment of Heiner Dreismann, a non-independent director, to the company's board on Oct. 31, 2006, Nanogen said.
Gene Logic has promoted Van Wyck Brinkerhoff to the post of senior vice president of administration. He will receive a $100,000 cash incentive bonus and a $250,000 executive cash incentive target for 2007.
Brinkerhoff joined Gene Logic in 2005 as senior vice president and general manager for its preclinical contract research business.
Prior to joining Gene Logic, he was group vice president for operations at Wilson Greatbatch Technologies. Earlier, he held senior management positions with Life Technologies, now Invitrogen.
ExonHit Therapeutics has appointed Deborah Smeltzer to its supervisory board. Smeltzer is CFO and vice president of operations at Dynavax Technologies. She formerly was vice president and general manager of Applied Biosystems’genetic-analysis business, and had been CFO and a vice president at Genset.
MWG Biotech has tapped Avril Hamilton for the post of UK and Ireland sales manager, and hired Krish Sakhamuru as key account salesperson.
Before joining MWG, Hamilton was senior European territory manager at Cogenics and was in sales at PerkinElmer and Bio-Rad.
Sakhamuru was an account manager with Elsevier MDL and Informax.